Temporomandibular Joint Dysfunction Syndrome Clinical Trial
Official title:
Respiratory Functions and Respiratory Muscle Strength in Patients With Temporomandibular Joint Dysfunction
NCT number | NCT05271396 |
Other study ID # | ssaka3 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 6, 2021 |
Est. completion date | February 11, 2022 |
Verified date | March 2022 |
Source | Halic University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
In our study, it was aimed to evaluate respiratory functions and respiratory muscle strength in patients diagnosed with temporomandibular dysfunction (TMD) and to compare them with healthy individuals. The study was conducted with a total of 46 participants, 23 of whom were diagnosed with TMD and 23 healthy individuals, at Batman Training and Research Hospital between August 2021 and December 2021. In the evaluation, the demographic information and clinical findings of the participants were recorded. Mandible movements were evaluated with a digital caliper. For TMJ, the Visual Analogue Scale (VAS) was used to measure the severity of pain at rest and during activity. Cervical lordosis and shoulder posture assessment was done by distance measurement. Fonseca Anamnestic Index was used for TMD severity classification. Spirometric measurement was performed to evaluate respiratory functions of all participants and intraoral pressure measurement was performed to determine respiratory muscle strength. Statistical analyzes were performed using the IBM SPSS Statistics 26 program. Significance level was accepted as p<0.05.
Status | Completed |
Enrollment | 46 |
Est. completion date | February 11, 2022 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 17 Years to 50 Years |
Eligibility | Inclusion Criteria: - Volunteer to participate in the study. - To be diagnosed with TMD for the TMD group, - To be healthy according to WHO definition for healthy matched group - Being between the ages of 17-50. Exclusion Criteria: - Having any previous pulmonary disease. - To have experienced a TMD problem due to trauma. - Having covid-19 in the last 6 months. |
Country | Name | City | State |
---|---|---|---|
Turkey | Haliç University | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Halic University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | FEV1 (liter) | This is the amount of air with pulmonary function test that the patient can force out of their lungs in one second. | at the enrollment | |
Primary | FEV1 (%-percentage) | This is the percentage of air with pulmonary function test that the patient can force out of their lungs in one second. | at the enrollment | |
Primary | FVC (liter) | This is the greatest total amount of air patient can forcefully breathe out after breathing in as deeply as possible. | at the enrollment | |
Primary | FEV1/FVC (percentage) | The FEV1/FVC ratio is a number that represents the percentage of patient lung capacity patient is able to exhale in one second. | at the enrollment | |
Primary | Inspiratory muscle test | Maximal inspiratory pressure (MIP) is going to measured using a mouth pressure meter (MicroRPM; MicroMedical, UK) according to the guideline of ATS and European Respiratory Society (ERS). | at the enrollment | |
Primary | Expiratory muscle test | Maximal expiratory pressure (MEP) is going to measured using a mouth pressure meter (MicroRPM; MicroMedical, UK) according to the guideline of ATS and European Respiratory Society (ERS). | at the enrollment | |
Secondary | Evaluation of Mandible Movements | Maximum mouth opening was evaluated with a digital caliper. In the measurement of maximum mouth opening, the patient was asked to open his mouth as wide as possible. The distance between the cutting edge of the upper incisor and the cutting edge of the lower incisor was measured in mm. | at the enrollment | |
Secondary | Cervical Lordosis and Shoulder Posture Evaluation | Auxiliary tools such as double-tri square, caliper, tape measure and ruler were used for distance measurements. While the patient was standing, the wall behind was taken as a reference, and the wall-acromion, wall-tragus, tragus-acromion and chin sternal notch were measured in centimeters (cm) in free posture. Participants were asked to look straight ahead, in the free posture used in daily life, their heels against the wall, their feet open at hip level. Measurements were made on the right and left sides with the help of ruler and tape measure. | at the enrollment | |
Secondary | Pain assessment | The Visual Analogue Scale (VAS) was used to evaluate the pain intensity of the participants at rest and during activity for the temporomandibular joint. The participants were told what the meaning of the number values between 0 and 10 on the horizontal chart, divided into 10 equal parts of 100 mm. "No pain" was 0 points, "Unbearable pain" was 10 points, "Moderate pain" was 5 points. Participants were asked to mark one of the values in line with these explanations and the values were recorded. | at the enrollment | |
Secondary | Temporomandibular joint dysfunction classification (Fonseca Index) | Fonseca Index consists of 10 questions. Participants were asked to answer each question. The scoring method was calculated as 'Yes (10 points)', 'Sometimes (5 points)' and 'No (0 points)'.
Classification; TMD-No (0-15 points), Mild-TMD (20-45 points), Moderate-TMD (50-65 points), and Severe-TMD (70-100 points) |
at the enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05006963 -
Tele-Rehabilitation in Patients With Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT03596606 -
Additional Effects of Therapeutic Exercises Under a Behavioral Umbrella for Chronic Temporomandibular Disorders Treatment
|
N/A | |
Completed |
NCT06005922 -
The Effectiveness of Temporomandibular Joint Mobilization and Exercise in Individuals With Chronic Neck Pain
|
N/A | |
Completed |
NCT04477122 -
Effects of Radial Shock Wave Therapy in the Treatment of Temporomandibular Joint Syndrome.
|
N/A | |
Recruiting |
NCT06134310 -
Efficacy of Manual Therapy Based on the Fascial Distortion Model in Individuals With Temporomandibular Disorder
|
N/A | |
Completed |
NCT02295644 -
Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial
|
N/A | |
Completed |
NCT05901701 -
Efficacy of Low Level LASER Therapy in Treating Temporomandibular Muscle Disorders
|
N/A | |
Recruiting |
NCT05802953 -
Quality of Life in Temporomandibular Joint Dysfunction
|
||
Recruiting |
NCT04831346 -
Effects of Low-Level Laser Therapy on Mouth Opening and Surface Electromyography in Temporomandibular Disorders
|
N/A | |
Completed |
NCT05893251 -
Effectiveness of Cervical Treatment in Wind Musicians With Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT03036215 -
Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology
|
N/A | |
Completed |
NCT06141863 -
Temporomandibular Dysfunction in Patients With Cervical Disc Herniation
|
||
Completed |
NCT01800279 -
Physiotherapy and Deontology in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome.
|
N/A | |
Recruiting |
NCT00870922 -
Effects of Masseter Manual Therapy on Temporomandibular Dysfunction
|
Phase 1 | |
Completed |
NCT03622684 -
Progressive Muscle Relaxation According to Jacobson in Treatment of the Patients With Temporomandibular Joint Disorders
|
N/A | |
Completed |
NCT03512769 -
Feasibility Testing of a New Way to Support the Jaw During 3rd Molar Extractions
|
||
Withdrawn |
NCT01954511 -
Manual Therapy and Exercises Applied to Cervical Spine in Patients With Temporomandibular Disorders
|
N/A | |
Recruiting |
NCT04609748 -
Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.
|
Phase 2 | |
Withdrawn |
NCT02202070 -
Botox for Treatment of TMJ Disorder With Bruxism
|
Phase 1 | |
Terminated |
NCT00716807 -
Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
|
N/A |